Tau and α-synuclein
Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
5
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
14
Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology
15
The Role of α-synuclein and Tau Hyperphosphorylation-Mediated Autophagy and Apoptosis in Lead-induced Learning and Memory Injury
10
Extensive aggregation of α-synuclein and tau in juvenile-onset neuroaxonal dystrophy: an autopsied individual with a novel mutation in the PLA2G6 gene-splicing site
11
Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level
13
What we can learn from animal models about cerebral multi-morbidity
9
Interleukin-1 mediates Alzheimer and Lewy body pathologies
9
Extracellular α-synuclein levels are regulated by neuronal activity
8
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
11
α-synuclein in the pathophysiology of Alzheimer’s disease
19
Efficient RT QuIC seeding activity for α synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy
14
The direct and indirect effects of α-synuclein on microtubule stability in the pathogenesis of Parkinson’s disease
11
Review Article Tissue Transglutaminase, Protein Cross-linking and Alzheimer’s Disease: Review and Views
14
Protein behavior in crowded environments
113
Original Article Silencing of SIAH1 in SH-SY5Y affects α-synuclein degradation pathway
8
α-Synuclein in gut endocrine cells and its implications for Parkinson’s disease
14
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
14
Pathological alpha-synuclein propagates through neural networks
12
α Synuclein interacts with lipoproteins in plasma
8